$SGMO News Article - Sangamo Therapeutics Announce
Post# of 55
(Total Views: 265)
Posted On: 03/29/2022 11:06:12 AM
$SGMO News Article - Sangamo Therapeutics Announces Dosing of First Patient in Phase 1/2 Clinical Study of Investigational CAR-Treg Cell Therapy TX200 in Kidney Transplantation https://marketwirenews.com/news-releases/sang...88545.html
(0)
(0)Sangamo BioSciences Inc. (SGMO) Stock Research Links
My Twitter: WhyteStocks
Scroll down for more posts ▼